Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.51 HKD
−194.36 M HKD
0.00 HKD
204.69 M
About SHANGHAI BIO-HEART BIOLOGICAL TECHN
Sector
CEO
Li Wang
Website
Headquarters
Shanghai
Founded
2014
ISIN
CNE100004JH3
FIGI
BBG013JZV045
Shanghai Bio-Heart Biological Technology Co., Ltd. engages in the research and development of interventional cardiovascular device therapies. It focuses on bioresorbable scaffold therapy addressing the unmet medical needs of Chinese patients for the treatment of coronary or peripheral artery diseases and renal denervation therapy addressing the unmet medical needs of patients for the treatment of uncontrolled hypertension and resistant hypertension. The company was founded by Li Wang and Guo Hui Wang on July 18, 2014 and is headquartered in Shanghai, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 2185 is 1.60 HKD — it has decreased by −3.61% in the past 24 hours. Watch SHANGHAI BIO-HEART BIOLOGICAL TECHN stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on HKEX exchange SHANGHAI BIO-HEART BIOLOGICAL TECHN stocks are traded under the ticker 2185.
2185 stock has risen by 0.63% compared to the previous week, the month change is a −13.51% fall, over the last year SHANGHAI BIO-HEART BIOLOGICAL TECHN has showed a −54.29% decrease.
2185 reached its all-time high on Aug 19, 2022 with the price of 75.55 HKD, and its all-time low was 1.26 HKD and was reached on Aug 26, 2024. View more price dynamics on 2185 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
2185 stock is 0.00% volatile and has beta coefficient of 1.31. Track SHANGHAI BIO-HEART BIOLOGICAL TECHN stock price on the chart and check out the list of the most volatile stocks — is SHANGHAI BIO-HEART BIOLOGICAL TECHN there?
Yes, you can track SHANGHAI BIO-HEART BIOLOGICAL TECHN financials in yearly and quarterly reports right on TradingView.
SHANGHAI BIO-HEART BIOLOGICAL TECHN is going to release the next earnings report on Mar 26, 2025. Keep track of upcoming events with our Earnings Calendar.
2185 net income for the last half-year is −27.99 M HKD, while the previous report showed −96.91 M HKD of net income which accounts for 71.12% change. Track more SHANGHAI BIO-HEART BIOLOGICAL TECHN financial stats to get the full picture.
No, 2185 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 18, 2024, the company has 32.00 employees. See our rating of the largest employees — is SHANGHAI BIO-HEART BIOLOGICAL TECHN on this list?
Like other stocks, 2185 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHANGHAI BIO-HEART BIOLOGICAL TECHN stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHANGHAI BIO-HEART BIOLOGICAL TECHN technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHANGHAI BIO-HEART BIOLOGICAL TECHN stock shows the sell signal. See more of SHANGHAI BIO-HEART BIOLOGICAL TECHN technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.